Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx-to-OTC switch products represent $125 mil. a year in Eckerd sales, exec says.

This article was originally published in The Tan Sheet

Executive Summary

ECKERD Rx-TO-OTC SWITCH PRODUCT SALES TOTAL $125 MIL. ANNUALLY, Senior VP, Merchandising & Purchasing Enzo Cerra said at the Non-prescription Drug Manufacturers Association's annual regulatory/marketing seminar in East Rutherford, N.J. "The Rx-to-OTC shift in over-the-counter drugs is [a]...major factor that's driving our business," Cerra noted. "Consider that we now do...over $125 mil. each year in Rx-to-OTC switch products."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088241

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel